FDA inspection
Reyman Drug Company Inc: FDA inspection ending Mar 3, 2000
FDA inspection 15768 · Baltimore, MD
Key facts
| Inspection ID | 15768 |
|---|---|
| Firm | Reyman Drug Company Inc |
| FEI number | 1110238 |
| Address | 817 E Baltimore St |
| City | Baltimore |
| State | MD |
| ZIP | 21202-4729 |
| Fiscal year | 2000 |
| Inspection end date | Mar 3, 2000 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data